First At-Home Self-Test for COVID-19 Receives FDA Emergency Use Authorization
On November 17, the United States Food and Drug Administration (FDA) issued an emergency use authorization for the first COVID-19 diagnostic self-test that can be taken at home. Manufactured by Lucira, the COVID-19 All-In-One Test Kit uses a self-collected nasal swab sample that is placed in the device. After 30 minutes, the test kit notes the sample is either positive or negative for SARS-CoV-2 via a lighted display. The test is designed for at-home use by those who may have COVID-19 as determined by their healthcare provider, and at point-of-care settings such as medical offices, hospitals, urgent care centers, and emergency departments. Read more here.